Terry Chrisomalis

Formal First Name

Terry

Links

Location

Terry Chrisomalis is the Founder and Author of Biotech Analysis Central at Seeking Alpha, a research service for both new and seasoned investors looking to gain knowledge in the biotechnology space. With a focus on due diligence, he provides insights and recommendations on various biotech companies and their potential value. Terry is a private investor in the biotechnology sector with years of experience utilizing his applied science background to generate long term value from healthcare. He is also a Contributor to TalkMarkets and Stocktwits.

Entity Types

Industries

Terms

	Entrepreneurship
	Small Business

Research

CURRENT AFFILIATIONS

Biotech Analysis Central aims to help investors better understand the biotechnology space.
As the service's author, he covers news, analysis, and opinions related to biotech companies, developments in biotech research, clinical trials, and market trends.
The newsletter service contains a library of 600+ biotech investing articles, a model portfolio of 10+ small and mid-cap stocks with deep analysis for each, live chat, and a range of analysis and news reports to help healthcare investors make informed decisions.

EXPERTISE

Terry has been investing and writing about biotechnology stocks for many years.
He has a demonstrated history of working in the internet industry, and writes about the healthcare sector and the stock market in general.
He is also skilled in business, entrepreneurship, and the pharmaceutical industry.

WRITING CAREER

Terry writes about biotechnology, healthcare, the stock market, technology, and pharmaceuticals.
He is a stock enthusiast at Stocktwits where he writes BiopharmaPro, a research newsletter with 65,000 followers.
He started his career as a Freelance Contributor at The Motley Fool, where he wrote about biotech and pharma stocks.

People